Clinical Trial Update: Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

View source ↗

Summary

A prospective cohort study at Peking University Third Hospital is evaluating Fuzheng Yangxin Prescription to aid rapid rehabilitation in patients with Qi-Yin de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Fuzheng Yangxin Prescription

Snippet

Sponsor: Peking University Third Hospital | Conditions: Coronary Artery Bypass | Status: RECRUITING